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Rapid reviews are increasingly used to replace or complement systematic reviews to support 




To assess the difference between rapid and systematic review approaches for a case study of 
test accuracy of succinylacetone for detecting tyrosinemia type 1.  
 
Methods 
Two reviewers conducted a rapid then a systematic review. The rapid review involved 
narrower searches, a single reviewer with 20% checking for screening the titles/abstracts and 
data extraction, and quality assessment using an unchanged QUADAS-2. Two reviewers 
performed the systematic review with a tailored QUADAS-2. Post-hoc analysis examined 
rapid reviewing with just a single reviewer (basic rapid review). 
 
Results 
The rapid and systematic reviews identified the same 10 papers, although one paper was only 
identified in the rapid review through checking included studies’ references. 2176 fewer 
title/abstracts and 129 fewer full-texts were screened during the rapid review. The unadjusted 
QUADAS-2 generated more ‘unclear’ ratings [29/70 (41.4%) compared to 16/70 (22.9%)], 
and fewer ‘high’ ratings [22/70 (31.4%) compared to 42/70 (60.0%)] than the systematic 
review using the adjusted QUADAS-2. A rapid review using a single reviewer would have 
missed up to four eligible studies during screening of titles/abstracts, and contained important 
inaccuracies in data extraction detected through use of a second reviewer.  
 
Conclusions 
Rapid reviews with 20% checking by a second reviewer appears to be an appropriate tool for 
policy-makers to expeditiously assess evidence. Single reviewer rapid reviews have higher 
risks of important inaccuracies and omissions. 
 
Keywords: Systematic review, Rapid review, Research methods, Evidence Based Practice, 
Literature searching 
1. Introduction 
Rapid reviews (also referred to as “rapid evidence reviews” or “rapid evidence assessments”, 
REAs) have received increased interest and recognition across Europe, North America, and 
Australasia, where there are demands for expedited assessment of the latest evidence to 
facilitate health policy decisions (Hailey 2007; Watt et al 2008; Ganann et al 2010; PHE 
2015; Tsertsvadze et al 2015). As yet, there is no standard definition of or approach to REAs 
(Featherstone et al 2015; Polisena et al 2015). Broadly, they offer a streamlined alternative to 
the traditional systematic review process (Khangura et al 2012; NICE 2014). The following 
key differences between rapid and systematic reviews have been reported: REAs are 
produced more quickly, and are generally thought to require continuous engagement with the 
commissioning organisation throughout the document development process. They generally 
focus on a descriptive approach to synthesis in contrast to, for example, meta-analysis. 
Inferences from an REA tend to be more cautious and/or provisional (Watt et al 2008; PHE 
2015).  
The effect of using REA rather than systematic review methods is currently unclear. 
Edwards et al (2002) Edwards et al (2002)found that the average increase in the total number 
of randomised trials identified by using a second reviewer was 9 per cent, but that this ranged 
across pairs from 0 per cent (both reviewers individually identified all trials) to 32 per cent (a 
second reviewer identified an additional seven trials) (Edwards et al 2002). Further they 
found that single reviewers missed on average 8 per cent of eligible reports (range 0 to 24 per 
cent), whereas pairs of reviewers missed few or none (range 0 to 1 per cent). Watt and 
colleagues have suggested that exhaustive data searching may not greatly impact final 
conclusions and recommendations of a review (Watt et al 2008). In contrast, Helmer 
compared MEDLINE searching versus extended searching which included specialist 
databases, hand searching, reference list review, and personal communication with experts 
and found that systematic searching increased the number of studies found and decreased bias 
(Helmer et al 2001). Helmer suggests that the likelihood of extended searching impacting the 
number of items retrieved may depend on the content area and whether content is likely to be 
found in mainstream databases (Helmer et al 2001).  
Some reviews have found little difference in the conclusions of an REA when they are 
compared with those of full health technology assessment reports or systematic reviews on 
the same topic (Watt et al 2008; Watt et al 2008; Ganann et al 2010; Scott and Harstall 2012). 
However, authors of these reviews report that REAs have a narrower scope, less depth, and 
provide less detail in their recommendations. A scoping review of rapid reviews, found that 
in 84 papers, 50 different approaches to reviewing were used (Tricco et al 2015). There was a 
lack of reporting of duration of review in 73%, reference checking in 40%, limitations by 
language in 34%, and number of reviewers in 29% of rapid reviews. In addition, few REAs 
discussed limitations associated with or bias introduced by, the streamlining process. 
According to Scott & Harstall (Scott and Harstall 2012) the degree to which the individual 
components of a review influence its results is unclear. It is also unclear what the minimum 
essential elements might be for accurate and reliable results. Comparisons to date have been 
largely between multiple reviews conducted by different research teams, which may be 
biased due to potential systematic differences between teams of researchers who conduct 
rapid and systematic reviews.  
The aim of this research was to compare the findings of a traditional SR with REA 
conducted by the same research team. We used a case study of a review of test accuracy of 




The protocol for the rapid review is registered at PROSPERO (registration number 
CRD42015026912) and was developed in close collaboration with the UK National 
Screening Committee, the commissioner. The rapid and systematic review approaches 
employed different search strategies, and methods for screening of titles and abstracts, 
assessment of full text articles, extraction, and quality appraisal. The same two reviewers 
conducted both reviews, first the REA and then the full review with no changes of staffing. 
No task other than quality appraisal was repeated twice by any individual reviewer, i.e. the 
data extraction from the REAs was also used in the SR. The methods used for the REA and 




2.1 Identification and selection of studies 
Both the REA and SR searches were conducted in Medline, Pre-Medline, Embase, and the 
Cochrane Library. The REA also included Web of Science (WoS) Core Collection, while the 
SR included WoS All Databases. The search strategy for the REA was narrower, for example 
the search terms for the condition were related to tyrosinemia type 1 only, whereas in the SR 
the terms were broadened to ‘tyrosinemia type 1’ or ‘inborn errors of metabolism’. In the 
REA approaches search terms for the screening test were related to ‘succinylacetone’ only, 
whereas in the systematic review this was broadened to include ‘tandem mass spectrometry’ 
and ‘newborn screening’ (see Supplement 1 and Supplement 2 for complete search 
strategies). Searches for both reviews were performed on 26th January. 
 
2.2 Eligibility criteria 
English language journal articles which investigated screening for TYR1 by tandem mass 
spectrometry (TMS) analysis of SUAC from dried blood spots in newborn infants were 
included in all reviews. The reference standard for both reviews was urine testing for SUAC 
and/or subsequent clinical detection of TYR1. Outcomes included test accuracy from cross-
sectional test accuracy, case-control, or cohort studies. Exclusion criteria were non-human 
studies, papers not available in the English language, letters, editorials and communications, 
grey literature, conference abstracts, and studies published before 2004 (the year the first 
study of TMS measurement of SUAC in dried blood spots was published).  
 
2.3 Screening and data extraction 
Screening of titles and abstracts of all retrieved records, and subsequently of full texts was 
conducted by one reviewer for the REA, with a second reviewer checking a random 20% full 
independent screening by two reviewers for the SR. Data extraction was performed by a 
single reviewer, with 20% and 100% checked by a second reviewer for the rapid and 
systematic reviews, respectively. 
 
2.4 Quality appraisal 
For the REA, quality appraisal was undertaken by one reviewer using QUADAS-2 which, 
contrary to the guidelines for use of the tool, was not tailored to the question. 20% of 
assessments were independently assessed by a second reviewer. For the full systematic 
review, risk of bias was assessed using the QUADAS-2 which was tailored to the research as 
recommended, and assessment was undertaken independently by two reviewers for all 
studies. Tailoring of the QUADAS-2 tool included adding a topic-specific signalling question 
and defining appropriate reference standards and cut-offs for participant exclusions as well as 
guidance on how many positive signalling questions are required for an overall positive 
rating in terms of bias and applicability concerns. The systematic review was conducted after 
the REA, so that the reviewers undertaking untailored QUADAS-2 could not benefit from 
their experience using a tailored QUADAS-2. 
 
2.5 Data summary and synthesis 
Descriptive statistics were calculated for the differences between the REA and systematic 
review in the number of papers found in each search, the number of full-texts accessed, and 
the number of papers included. Narrative comparisons were made between the data extracted 
and the quality appraisal scores between the two reviews. 
 
2.6 Post hoc analyses 
The approach to REA used here is arguably more comprehensive than some other REA 
processes. To explore the impact of this we conducted a post hoc comparison of the effect 
that using an REA with fewer resources would have had on the findings. This approach 
comprised a single reviewer, a search limited to electronic databases only, no checking of 
references, and the use of the unadjusted QUADAS-2 (see table 1 for full details). We refer to 
this approach as a ‘basic REA’, to contrast it our more comprehensive REA (which we refer 
to as an ‘enhanced REA’). Single reviewer data were available from reviewer A and reviewer 
B, giving us two ‘case studies’ of this approach. 
 
3. Results 
3.1 Searching and screening of titles/abstracts 
Figure 1 provides the PRISMA flow diagram for the REA and systematic review searches. 
We identified 310 unique records in each of the basic and enhanced REAs, and 1274 in the 
systematic review. After screening titles and abstracts, 19 (6%) were retained for the basic 
REA by reviewer A and 25 (8%) by reviewer B, 19 (6%) for the enhanced REA, and 76 (6%) 
for the systematic review. In the basic REA nine (47%) of the full text articles were included 
after assessment against inclusion criteria by reviewer A and 5 (20%) by reviewer B. In the 
enhanced REA, nine (47%) of the full text articles were include with one additional paper 
(Lund et al 2012) identified by reference checking of a previous review (Bazian 2014). In the 
systematic review, 10 (13%) of 76 full-text articles were included in the review. The same 10 
articles were included after screening the titles/abstracts in each of the enhanced REA and 




In the basic REA, there was no difference in the number of titles/abstracts that were screened 
by reviewers A and B. However, reviewer B examined 13 more full texts than reviewer A. 
There were no differences between either of the basic REAs and the enhanced REA in terms 
of the number of titles/abstracts that were screened. Compared to each of the basic REAs, the 
enhanced REA resulted in the examination of 0 (reviewer A) or 13 (reviewer B) additional 
full texts. The systematic review resulted in an extra 964 titles/abstracts being screened 
compared to each of the basic REAs, and an extra 964 titles/abstracts by reviewer A and 1212 
by reviewer B (as reviewer A only screened 20% of the titles/abstracts in the rapid review) 
compared to the enhanced REA. The systematic review resulted in the assessment of an 
additional 57 or 51 full texts compared to reviewers A and B, respectively, in the basic REA, 
and the examination of an additional 57 full texts compared to the enhanced REA. The 
additional study identified by reference checking in the enhanced REA was an observational 
cohort describing screening of 504,049 newborns in Denmark, the Faroe Islands and 
Greenland (Lund et al 2012). It was missed by the REA electronic searches as this article did 
not contain the search terms for ‘tyrosinemia’ in title or abstract, only broader terms like 
‘inborn errors of metabolism’ or ‘IEM’. 
 
3.2 Quality assessment 
Using unadjusted QUADAS-2 in the basic and enhanced REAs resulted in more ‘unclear’ 
and fewer ‘high risk’ ratings for both risk of bias and applicability concerns than the adjusted 
QUADAS-2 used in the full systematic review. Using an adjusted QUADAS-2 tool with 
guidance notes reduced the total number of ‘unclear’ ratings from 26 of 63 (41%) in the basic 
REA by reviewer A and 10 of 35 (29%) by reviewer B, and 29 of 70 (41.4%) in the enhanced 
REA to 16 of 70 (22.9%) in the systematic review. The number of ‘high’ ratings increased 
from 21 of 63 (33%) in the basic REA by reviewer A and 12 of 35 (34%) by reviewer B, and 
22 of 70 (31.4%) in the enhanced REA to 42 of 70 (60.0%) in the systematic review. This 
difference is particularly apparent in the reference standard domain, where in the rapid review 
1/10 studies were rated high risk of bias and 0/10 had high applicability concerns, whereas in 
the systematic review 7/10 were rated high risk of bias and 7/10 had high applicability 




3.3 Data extraction and review findings 
Differences were found within the basic REAs (reviewer A versus reviewer B), and between 
the basic REAs and the enhanced REA/SR approaches, in relation to data extracted and 
review findings. Using the basic REA methods (which did not include screening reference 
lists) would have resulted in missing one relevant paper (Lund et al 2012). The use of a single 
reviewer would have affected our results at every stage of the review process. At the 
screening the titles/abstracts stage, a single reviewer would not have missed any records (if it 
was reviewer A) but one record if reviewer B was the only reviewer. Full text assessment by 
a single reviewer would have either missed no records (if it was reviewer A) or 4 eligible 
records (if it was reviewer B). Most importantly, using single data extraction would have 
resulted in extracting and calculating inappropriate sensitivity, specificity and negative 
predictive values for six prospective studies (if it was reviewer A). These studies reported 
sensitivity and specificity, but it was inappropriate to use due to lack of follow up of negative 
cases with any reference standard test. The inclusion of a second reviewer (20% for the REA 
or 100% for the SR) prevented these omissions and errors occurring. 
We found no differences between the enhanced REA and SR approaches to data extracted 
or overall review findings. Using enhanced REA and SR approaches, ten studies were 
identified that provided data on test accuracy of the SUAC newborn blood spot screening test 
for TYR1. Five studies reported results from prospective newborn screening programmes 
(Sander et al 2006; la Marca et al 2011; Morrissey et al 2011; Lund et al 2012; Zytkovicz et 
al 2013), and four reported results from case-control studies used stored DBS samples from 
confirmed TYR1 patients and healthy controls (Allard et al 2004; la Marca et al 2008; 
Turgeon et al 2008; Dhillon et al 2011; Metz et al 2012). It was not possible to calculate 
sensitivity, specificity, or negative predictive values due to lack of follow up of screen 
negative results. Positive predictive values (PPV) from four prospective screening studies 
using SUAC as primary marker was 100% (6 true positive cases out of 717,501 people 
screened) in three studies (Sander et al 2006; Lund et al 2012; Zytkovicz et al 2013), and 
67% (2 true positive cases and 1 false positive case out of ~500,000 people screened) in one 
study (Morrissey et al 2011). PPV could not be calculated in two studies (la Marca et al 2011; 
Metz et al 2012).  
 
4. Discussion 
4.1 Summary of findings 
We conducted a case study to compare the impact of reducing or eliminating some of the 
steps of a full SR by undertaking a REA. We investigated the number of relevant studies 
missed and the frequency of errors in a review of a newborn screening test for TYR1. This 
comparison suggests that for this particular topic, a REA with 20% checking by a second 
reviewer and checking references of included studies identified the same number of relevant 
studies as did a broader SR search but with a reduced amount of effort, time, and resources.  
A key difference between the SR and REA approaches was the use of an adjusted 
(SR) and unadjusted (basic and enhanced REA) QUADAS-2 tool. This has a substantial 
impact on the interpretation of the review findings. Using an unadjusted QUADAS-2 resulted 
in risks of bias/applicability concerns that could not be qualified in a large proportion of the 
studies (29 – 41% of total ratings). Conversely, tailoring the QUADAS-2 tool in the SR 
resulted in clearer estimates of risk of bias/applicability. In particular, in the reference 
standard domain there were more papers in the SR with high risk of bias and applicability 
concerns. Overall, 60% of total ratings were for high risks of bias/applicability concerns, and 
only 23% were for unclear risks of bias/applicability concerns. Therefore, the adjusted 
QUADAS-2 (used in the SR) improved our understanding of the risks of bias/applicability 
concerns within the studies, and indicated that, due to the large proportion of studies with 
potential biases, we should exercise caution in the interpretation of results. 
Post hoc analysis indicated that a less thorough REA (that searched fewer sources, 
and used a single reviewer only) may have generated substantial errors that would have 
impacted on test accuracy estimates produced.  
 
4.2 Strengths and limitations  
Previous comparisons of REA and SR have typically looked at reviews that were conducted 
by different review teams. In these instances we cannot know if disparities in the results are 
caused by variation in the methodologies used or difference in the abilities and experience of 
the reviewers. In our study the same two reviewers conducted the rapid review, then the 
systematic review analysing an identical review question. This reduced the confounders 
introduced by variation between reviewers in comparisons between rapid and systematic 
reviewing methods. The reviewers both had significant systematic reviewing experience at 
the beginning of the study, and some experience of test accuracy reviewing. Our post hoc 
analyses indicated that using a single reviewer showed significant potential errors could arise 
from this. This result is likely to be generalisable to others because of the level of experience 
of the reviewers, and because the main error (reporting sensitivity and specificity directly 
from the studies without checking for follow up of negative results to an adequate reference 
standard) was also made in a previous review on this topic (Bazian 2014), which used a 
single reviewer method.  
Our review has a number of limitations. First, our systematic review was not carried 
out in a blinded manner; as the REA was conducted first, the reviewers had prior knowledge 
of what evidence was available and had made an assessment about the studies and their 
quality before the SR began. We cannot be sure that the results of the SR would have been 
exactly the same if the SR had been conducted independent of the REA. Second, the decision 
to examine the impact of a more basic review that did not include a second reviewer (and to 
compare reviewer A versus reviewer B) was made after the reviews had been completed. The 
results of these elements of our review should be considered to be exploratory. More 
generally, a key limitation to this approach is that this is only a single case study. Caution 
must be exercised in making generalisations to other reviewers, or topics. For this topic both 
the condition (TYR1) and the test (TMS measurement of SUAC) are rare. Refining search 
terms and screening of titles/abstracts are both relatively straight forward in this topic area so 
the findings demonstrate the difference between REAs and full systematic reviews very 
clearly. However it may not be appropriate to generalise to more complex topics or to those 
with a larger evidence base. Finally, the included studies did not include adequate 
information to populate the 2x2 tables, so we could not calculate whether omission of the 
paper by (Lund et al 2012), which would have been missed in a more minimal search would 
have changed the study conclusions. 
 
4.3 Comparison to other studies 
Our research is broadly consistent with prior studies which have compared REA and SR 
approaches. Similar to Edwards et al (2002), we found evidence that single reviewers missed 
more eligible papers than pairs of reviewers; in our study this was dependent upon which 
reviewer was being evaluated. This suggests that individual reviewer characteristics are an 
important contributor to review accuracy when a single reviewer only is used. Further, while 
there were clear differences between our REA and SR in terms of the scope and depth of 
searches, like Ganann et al (2010); Scott and Harstall (2012), and (Watt et al 2008; Watt et al 
2008) these did not affect our overall conclusions. 
4.4 Implications for policy and practice 
The appropriateness of deciding to use a rapid rather than systematic review may depend on 
purpose and context. REA and SR are not equal or interchangeable, rather they often serve 
different purposes. The purpose of an REA is not to provide a definitive answer to the 
effectiveness of a particular intervention but, for example, to provide sufficient information 
on which to decide next steps, including whether, and what, further work is required before a 
decision can be made, e.g. if different types of evidence are required (primary research, cost-
effectiveness studies) or if a full systematic review is warranted. Depending on the findings 
of the REA, a policy makers might see a justification for a systematic review when a body of 
evidence (of sufficient volume and quantity) is identified that could be explored using meta-
analysis to better characterise, for example, treatment effects, or a need to more thoroughly 
investigate issues of bias is presented. While a SR would answer questions about where 
evidence is lacking, it would do so at the price of time and resources with no guarantees that 
it would provide useful additional information that an REA would not. Indeed, there is 
evidence of this in our own review; in the context of a 3-yearly update review developed in 
consultation with stakeholders and experts, to guide policy-makers on whether this topic 
merits further investigation and  future research questions, the conclusions from the  REA 
were not altered by the SR. This research thus provides some evidence that rapid reviewing 
(with 20% checking by a second reviewer) may be an effective method of triage, to determine 
whether there is a need for a full systematic review. REAs may also be of value in the 
identification of focused topics requiring SRs and the provision of an estimate of the volume 
of literature which might be expected and some of the quality issues likely to be encountered.  
However, even for the rare disease and uncommon test evaluated here, use of a full adjusted 
QUADAS-2 increased the estimates of bias in comparison to a rapid unadjusted QUADAS-2, 
indicating that REA is not a replacement for a full systematic review, particularly if the rapid 
review recommends implementation of a new treatment, test or screening programme. This 
review also provides some evidence that rapid reviewing with a single reviewer only may not 
be an effective approach to reviewing the evidence, and that there may be significant benefit 
from 20% checking by a second reviewer.  
 REA and SR are not the only approaches to reviewing for policy makers. An 
alternative is a scoping review. Typically, scoping reviews do not seek to answer specific 
research questions using narrow criteria, nor do they include formal appraisal of the quality 
of literature, or a synthesis of evidence (Arksey and O'Malley 2005; Peters et al 2015). A 
range of uses of scoping reviews have been reported, including mapping of key concepts, 
identifying the extent evidence, determining if systematic reviews are justified, summarising 
and disseminating the findings of research, and identifying gaps in the literature (Arksey and 
O'Malley 2005). This approach may be more appealing to policy makers than REAs as it 
requires fewer resources and is less likely to ‘miss’ relevant literature. Like REAs, scoping 




For this rare disease with a single uncommonly used test, comparison of SR with REA 
methods did not affect our findings in terms of search yield or data extraction, but tailoring 
the QUADAS-2 tool in the SR resulted in higher estimates of risk of bias. A full SR approach 
dramatically extended the work load of searching and screening of titles/abstracts. REA 
involving only one reviewer with no checking by a second reviewer may have resulted in 
missed studies, and significant inaccuracies in data extraction. We consider that REAs are 
likely to have their place in the armamentarium for those providing information to policy 
makers and working closely with commissioners. A thorough preceding rapid review may 
point to the need for a further judgement as to where, how, when and in what circumstances a 
full systematic review might be the better option. 
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